Nirsevimab: Expansion of Respiratory Syncytial Virus Prevention Options in Neonates, Infants, and At-Risk Young Children.
Saved in:
| Title: | Nirsevimab: Expansion of Respiratory Syncytial Virus Prevention Options in Neonates, Infants, and At-Risk Young Children. |
|---|---|
| Authors: | Fly JH; Department of Clinical Pharmacy and Translational Science, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA.; Le Bonheur Children's Hospital, Memphis, TN, USA., Eiland LS; Harrison College of Pharmacy, Auburn University, Auburn, AL, USA., Stultz JS; Department of Clinical Pharmacy and Translational Science, College of Pharmacy, The University of Tennessee Health Science Center, Nashville, TN, USA. |
| Source: | The Annals of pharmacotherapy [Ann Pharmacother] 2025 Jan; Vol. 59 (1), pp. 81-91. Date of Electronic Publication: 2024 Apr 23. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Sage Country of Publication: United States NLM ID: 9203131 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-6270 (Electronic) Linking ISSN: 10600280 NLM ISO Abbreviation: Ann Pharmacother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1542-6270 |
|---|---|
| DOI: | 10.1177/10600280241243357 |
